Forgot Password.
By Logging in, you are agreeing to the MedSearch Global Terms of Use and Privacy Policy.
Not a member? Sign Up
By Signing up, you are agreeing to the MedSearch Global Terms of Use and Privacy Policy.
Have an account? Log in
Back to Login? Log in
By registering in, you are agreeing to the MedSearch Global terms and condition and Privacy Policy.
Thinking of joining a study?
Register your interest
7243 results
Interventional
Phase1
18
Cholestyramine
Leflunomide
Steroid Therapy
City of Hope Medical Center
Source: clinicaltrials.gov
Observational
Not Applicable
5000
Non-Interventional Study
Mayo Clinic
Phase2
30
Tucatinib
Eribulin
Trastuzumab
Criterium, Inc.
70
Glofitamab
Obinutuzumab
Polatuzumab Vedotin
Atezolizumab
Tocilizumab
Pester
Christine Ryan
100
Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)
60
Lumosity
Lumosity (waitlist control)
University of Alabama at Birmingham
565
Epcoritamab
Lenalidomide
Ibrutinib
Rituximab
Cyclophosphamide
Doxorubicin Hydrochloride [HCl]
Prednisone
Venetoclax
CC-99282
Genmab
320
IMM-1-104 Monotherapy (Treatment Group A)
IMM-1-104 + modified Gemcitabine/nab-Paclitaxel (Treatment Group B)
IMM-1-104 + modified FOLFIRINOX (Treatment Group C)
IMM-1-104 + dabrafenib (Treatment Group D)
IMM-1-104 + pembrolizumab (Treatment Group E)
Immuneering Corporation
300
HSCT with TBI Regimen
HSCT with Non-TBI Regimen
Masonic Cancer Center, University of Minnesota
10
Nivolumab
Irreversible Electroporation
University of Louisville